If the clinical trial industry is serious about promoting diversity, it's time to take a holistic approach to patient outreach and eschew its current "transactional" nature, says Chris Komelasky, CEO of SiteBridge Research.

[Read](https://acrpnet.org/2022/03/29/its-time-to-rethink-patient-engagement-strategy)

[Michael Causey's Clinical Trial Report with Chris Komelasky on SiteBridge's Community Engagement Approach](https://www.sitebridgeresearch.com/post/michael-causey-s-clinical-trial-report-with-chris-komelasky-on-sitebridge-s-community-engagement-app)